Back
Amgen, Inc. 10K Form
Sell
36
AMGN
Amgen, Inc.
Last Price:
$340.12
Seasonality Move:
9.51%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2025-07-15 | 10K | AMGN/Amgen, Inc. Annual |
| 2025-06-15 | 10K | AMGN/Amgen, Inc. Annual |
| 2025-05-15 | 10K | AMGN/Amgen, Inc. Annual |
| 2025-04-15 | 10K | AMGN/Amgen, Inc. Annual |
| 2025-03-15 | 10K | AMGN/Amgen, Inc. Annual |
| 2025-02-15 | 10K | AMGN/Amgen, Inc. Annual |
Receive AMGN News And Ratings
See the #1 stock for the next 7 days that we like better than AMGN
AMGN Financial Statistics
Sales & Book Value
| Annual Sales: | $33.2B |
|---|---|
| Cash Flow: | $4.2B |
| Price / Cash Flow: | 15.96 |
| Annual Sales: | $17.86 |
| Price / Book: | 19.04 |
Profitability
| EPS (TTM): | 12.93520 |
|---|---|
| Net Income (TTM): | $7B |
| Gross Margin: | $21.3B |
| Return on Equity: | 95.55% |
| Return on Assets: | 7.78% |
Amgen, Inc. Earnings Forecast
Key Amgen, Inc. Financial Ratios
-
The Gross Profit Margin over the past 41 years for AMGN is 64.19%.
-
The Selling, General & Administrative Expenses for AMGN have been equal to 21.35% of Gross Profit Margin.
-
The Research & Development expenses have been 17.08% of Revenue.
-
The Interest Expense is 78.83% of Operating Income.
-
The Net Earning history of AMGN is 12.31% of Total Revenues.
-
Per Share Earnings over the last 41 years have been positive in 27 years.
Amgen, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | AMGN |
| CUSIP: | 031162 |
| Website: | amgen.com |
Debt
| Debt-to-Equity Ratio: | 5.67 |
|---|---|
| Current Ratio: | 1.28 |
| Quick Ratio: | 0.82 |
Price-to-Earnings
| Trailing P/E Ratio: | 44.99 |
|---|---|
| Forward P/E Ratio: | 15.56 |
AMGN Technical Analysis vs Fundamental Analysis
Sell
36
Amgen, Inc. (AMGN)
is a Sell
Is Amgen, Inc. a Buy or a Sell?
-
Amgen, Inc. stock is rated a SellThe current Amgen, Inc. [AMGN] share price is $340.16. The Score for AMGN is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.